INCAGN01949
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for INCAGN01949, covering 2020-05-12 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma [Phase 1, Phase 2]